Literature DB >> 16710097

A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity.

Kaisa Valli-Jaakola1, Jorma J Palvimo, Marita Lipsanen-Nyman, Veikko Salomaa, Leena Peltonen, Kimmo Kontula, Camilla Schalin-Jäntti.   

Abstract

BACKGROUND/AIMS: Mutations in melanocortin-4 receptor (MC4R) are the most common genetic cause of human obesity. Mutations in MC4R promoter could also underlie obesity, but have so far not been reported. Transcription factor nescient helix-loop-helix 2 (Nhlh2) is a novel obesity candidate gene. We searched for mutations in MC4R promoter and Nhlh2 gene in 152 children with severe early-onset obesity. Lean subjects (n = 447) served as controls.
METHODS: MC4R promoter and Nhlh2 gene were investigated by sequencing. Gel shifts and reporter gene assays were used to investigate a deletion in MC4R promoter. Mutation carriers were carefully characterised. Weight charts from index patients and relatives were analysed.
RESULTS: We identified a deletion, -439delGC, in MC4R promoter in 2 severely obese, unrelated children and their family members, but not in controls. Index patients and mutation-carrying relatives were affected by early-onset obesity, while non-carriers had normal childhood weight development. The deletion is located at a potential Nhlh2-binding site and gel shift assays showed that Nhlh2 binds to this site. No significant differences in mutant compared to wild-type MC4R promoter activities were detected. No mutations were identified in Nhlh2 gene.
CONCLUSION: We report an MC4R promoter mutation, -439delGC, associated with early-onset obesity and show that transcription factor Nhlh2 recognises this site in vitro. Nhlh2 mutations unlikely underlie severe human obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710097     DOI: 10.1159/000093469

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  5 in total

1.  Melanocortin 4 receptor is a transcriptional target of nescient helix-loop-helix-2.

Authors:  Umesh D Wankhade; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

2.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

Review 3.  Nhlh2: a basic helix-loop-helix transcription factor controlling physical activity.

Authors:  Deborah J Good; Christopher A Coyle; Dana L Fox
Journal:  Exerc Sport Sci Rev       Date:  2008-10       Impact factor: 6.230

4.  Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

Authors:  A Kemal Topaloglu; Enver Simsek; Matthew A Kocher; Jamala Mammadova; Ece Bober; Leman Damla Kotan; Ihsan Turan; Can Celiloglu; Fatih Gurbuz; Bilgin Yuksel; Deborah J Good
Journal:  Hum Genet       Date:  2022-01-23       Impact factor: 5.881

5.  Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery.

Authors:  Marion Valette; Christine Poitou; Johanne Le Beyec; Jean-Luc Bouillot; Karine Clement; Sébastien Czernichow
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.